These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 20437882)
1. New rules on conflict of interest: what has to be done in Europe? Jirillo A; Vascon F Tumori; 2010; 96(1):180-1. PubMed ID: 20437882 [No Abstract] [Full Text] [Related]
2. Ethics and Disclosure. Pinzur MS Foot Ankle Int; 2019 Mar; 40(3):364. PubMed ID: 30700164 [No Abstract] [Full Text] [Related]
4. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
5. Shining a light on the Sunshine Act. Peck AA J Med Assoc Ga; 2013; 102(2):28. PubMed ID: 24006732 [No Abstract] [Full Text] [Related]
6. Analysis of American College of Cardiology/American Heart Association Guideline Author Self-Disclosure Compared With Open Payments Industry Disclosure. Dudum R; Sajja A; Amdur RL; Choi BG Circ Cardiovasc Qual Outcomes; 2019 Dec; 12(12):e005613. PubMed ID: 32522012 [No Abstract] [Full Text] [Related]
7. Readers want transparency in link between doctors and drug firms. Eaton L BMJ; 2003 Jun; 326(7403):1352. PubMed ID: 14682296 [No Abstract] [Full Text] [Related]
8. Already feeling the heat: Docs rethinking payments as Sunshine Act looms. Lee J Mod Healthc; 2013 Jul; 43(26):12-3. PubMed ID: 23878901 [No Abstract] [Full Text] [Related]
10. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine. Rubin EB; Bernat JL Headache; 2008; 48(10):1545-9. PubMed ID: 19076654 [No Abstract] [Full Text] [Related]
11. Letting the sunshine in on doctor-pharma relationships. Jack A BMJ; 2011 Oct; 343():d6459. PubMed ID: 21990283 [No Abstract] [Full Text] [Related]
12. Disclosure needs to include the extent of a relationship. Fisher CM Med J Aust; 2006 Dec 4-18; 185(11-12):673; author reply 674-5. PubMed ID: 17181524 [No Abstract] [Full Text] [Related]
13. IOM warns about physician-pharma conflicts of interest. Landers SJ; O'Reilly KB Del Med J; 2009 Jul; 81(7):261-3. PubMed ID: 19902777 [No Abstract] [Full Text] [Related]
14. Let the sunshine in--making industry payments to New Zealand doctors transparent. Farquhar C; Stokes T; Grey A; Jeffery M; Griffin P N Z Med J; 2015 Mar; 128(1411):6-12. PubMed ID: 25820497 [No Abstract] [Full Text] [Related]
15. Pharmaceutical company gifts: from voluntary standards to legal demands. Dresser R Hastings Cent Rep; 2006; 36(3):8-9. PubMed ID: 16776014 [No Abstract] [Full Text] [Related]
16. Transparency urged over research payments. Check E Nature; 2007 Aug; 448(7155):738. PubMed ID: 17700667 [No Abstract] [Full Text] [Related]
17. The pitfalls of misreading: what does "industry funding of medical education" actually say? Spielman B Am J Bioeth; 2010 Jan; 10(1):24-5. PubMed ID: 20077332 [No Abstract] [Full Text] [Related]
18. Trust in the medical literature--and Viewpoints in JAMA Internal Medicine. Steinbrook R; Redberg RF JAMA Intern Med; 2013 Jun; 173(12):1047-8. PubMed ID: 23609117 [No Abstract] [Full Text] [Related]
19. The AAMC exhibits the behavior it condemns. Stossel TP Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333 [No Abstract] [Full Text] [Related]